BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2458434)

  • 1. Relationship of dihydropyridine binding sites with calcium-dependent neurotransmitter release in synaptosomes.
    Massieu L; Tapia R
    J Neurochem; 1988 Oct; 51(4):1184-9. PubMed ID: 2458434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple calcium channels in synaptosomes: voltage dependence of 1,4-dihydropyridine binding and effects on function.
    Dunn SM
    Biochemistry; 1988 Jul; 27(14):5275-81. PubMed ID: 2458759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of lanthanum ions and ruthenium red to synaptosomes and its effects on neurotransmitter release.
    Tapia R; Arias C; Morales E
    J Neurochem; 1985 Nov; 45(5):1464-70. PubMed ID: 2413171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
    Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
    J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of [3H]serotonin release by dihydropyridines in spinal cord synaptosomes.
    Gandhi VC; Jones DJ
    Eur J Pharmacol; 1990 Oct; 187(2):271-80. PubMed ID: 1703081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic relevance of dihydropyridine binding sites in membranes from rat aorta: kinetic and equilibrium studies.
    Wibo M; DeRoth L; Godfraind T
    Circ Res; 1988 Jan; 62(1):91-6. PubMed ID: 2446799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of strychnine on the regulation of voltage-dependent calcium channels by dihydropyridines in brain and heart.
    O'Neill SK; Bolger GT
    Pharmacol Biochem Behav; 1990 Apr; 35(4):833-40. PubMed ID: 1693213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAY K 8644, a 1,4-dihydropyridine Ca2+ channel activator: dissociation of binding and functional effects in brain synaptosomes.
    Rampe D; Janis RA; Triggle DJ
    J Neurochem; 1984 Dec; 43(6):1688-92. PubMed ID: 6208338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the calcium-dependent stimulation of transmitter release by 4-aminopyridine in synaptosomes.
    Tapia R; Sitges M; Morales E
    Brain Res; 1985 Dec; 361(1-2):373-82. PubMed ID: 2867810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyridine binding sites regulate calcium influx through specific voltage-sensitive calcium channels in cerebellar granule cells.
    Carboni E; Wojcik WJ
    J Neurochem; 1988 Apr; 50(4):1279-86. PubMed ID: 2450173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
    Maan AC; Ptasienski J; Hosey MM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gamma-Aminobutyric acid release from synaptosomes as influenced by Ca2+ and Ca2+ channel blockers.
    Carvalho CM; Santos SV; Carvalho AP
    Eur J Pharmacol; 1986 Nov; 131(1):1-12. PubMed ID: 3816939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium entry activators: distinct sites of dihydropyridine and aminopyridine action.
    Greenberg DA; Cooper EC; Carpenter CL
    Neurosci Lett; 1984 Sep; 50(1-3):279-82. PubMed ID: 6208517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
    Greenberg DA; Carpenter CL; Messing RO
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1021-7. PubMed ID: 2427685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional distribution of calcium channel ligand (1,4-dihydropyridine) binding sites and 45Ca2+ uptake processes in rat brain.
    Skattebøl A; Triggle DJ
    Biochem Pharmacol; 1987 Dec; 36(23):4163-6. PubMed ID: 2446630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 4-aminopyridine on transmitter release in synaptosomes.
    Tapia R; Sitges M
    Brain Res; 1982 Nov; 250(2):291-9. PubMed ID: 6129030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
    Dunn SM; Bladen C
    Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of drugs on neurotransmitter release: experiments in vivo and in vitro.
    Tapia R
    Neurosci Biobehav Rev; 1985; 9(3):391-7. PubMed ID: 2415885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional dihydropyridine binding site associated with slow calcium channel in rat cultured neurones.
    Maloteaux JM; Octave JN; Laterre EC
    Neurosci Lett; 1988 Apr; 87(1-2):168-72. PubMed ID: 2454427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
    Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
    Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.